Abstract:Circulating tumor DNA (ctDNA) has emerged as a pivotal biomarker for cancers, offering a non-invasive means of detection through liquid biopsies. However, the current methodologies for ctDNA detection often struggle with sensitivity, especially when confronted with ultra-low concentrations. To address this challenge, we have engineered a remarkably sensitive electrochemical biosensor that can detect low concentration of ctDNA. This breakthrough is achieved by integrating a dual enzyme-assisted amplification mechanism with hybridization chain reaction (HCR). In the initial phase, the presence of ctDNA triggers the unfolding of the H2 hairpin structure, resulting in a segment of double-stranded DNA. The subsequent introduction of Klenow (3 '-> 5 ' exo-) and nicking endonuclease (Nb.BbvCI) enzymes leads to the abundant production of extended DNA (EXTDNA). This step critically enhances the initial amplification of the target DNA, ensuring superior specificity and selectivity thanks to the synergistic enzymatic activity. EXTDNA efficiently unfolds the H1 hairpin structure immobilized on the gold electrode, which acts as the initiation point for the HCR. Further amplification of the trace target DNA is achieved through an additional H3 and H4 hybrid-mediated HCR. Finally, the differential pulse voltammetry signal of methylene blue is increased significantly. Our results reveal that the developed electrochemical biosensor displays an exceptional linear correlation with ctDNA across concentrations ranging from 10 fM to 20 pM, with an unprecedented detection limit of 2.3 fM (3 s/k). This innovative approach shows immense potential for the ultrasensitive detection of ctDNA, promising broad applications in early cancer detection and monitoring.

CRISPR/dCas9-Mediated Specific Molecular Assembly Facilitates Genotyping of Mutant Circulating Tumor DNA.

CRISPR/Cas9 Cleavage Triggered ESDR for Circulating Tumor DNA Detection Based on a 3D Graphene/auptpd Nanoflower Biosensor.

A Novel CRISPR/Cas12a-Mediated Ratiometric Dual-Signal Electrochemical Biosensor for Ultrasensitive and Reliable Detection of Circulating Tumor Deoxyribonucleic Acid

CRISPR/Cas12a cleavage-mediated isothermal amplification lights up the dimeric G-quadruplex signal unit for ultrasensitive and label-free detection of circulating tumor DNA

CRISPR/Cas12a Bio-Assay Integrated with Metal-Organic Framework Based Enhanced Fluorescent Labels for Ultrasensitive Detection of Circulating Tumor DNA

CRISPR-dCas9 powered impedimetric biosensor for label-free detection of circulating tumor DNAs

Synthetic Gene Circuit-Based Assay with Multilevel Switch Enables Background-Free and Absolute Quantification of Circulating Tumor DNA.

Electrochemical-Fluorescent Bimodal Biosensor Based on Dual CRISPR-Cas12a Multiple Cascade Amplification for ctDNA Detection

An Ultra-Sensitive Electrochemical Biosensor for Circulating Tumor DNA Utilizing Dual Enzyme-Assisted Target Recycle and Hybridization Chain Reaction Amplification Strategies

Electrochemical Detection of Ctdna Mutation in Non-Small Cell Lung Cancer Based on CRISPR/Cas12a System

An Ultra-Sensitive CRISPR-Cas12a and Aptamer-Based Biosensor Utilizing Entropy-driven Catalytic DNA Networks for Precise Detection of DNA Methyltransferase 1

Controllable Assembly of a Quantum Dot-Based Aptasensor Guided by CRISPR/Cas12a for Direct Measurement of Circulating Tumor Cells in Human Blood.

Tetrahedral DNA Nanostructures-Assisted Electrochemical Assay for Detecting Circulating Tumor DNA by Combining a Masking Tactic with 3D-Hybridization Chain Reactions

Multivalent Duplexed-Aptamer Networks Regulated a CRISPR-Cas12a System for Circulating Tumor Cell Detection.

Integrating Cycled Enzymatic DNA Amplification and Surface-Enhanced Raman Scattering for Sensitive Detection of Circulating Tumor DNA

Multiplexed Detection of Mutant Circulating Tumor DNA Using Peptide Nucleic Acid Clamping Asymmetric Polymerase Chain Reaction and Liquidchip.

Advances in Mutant Detection of Circulating Tumor DNA

Spherical Nucleic Acid Reporter-Based Cascade CRISPR/Cas12a Amplifier for Stable and Sensitive Biosensing of Circulating Tumor DNA.

A Universal Electrochemical Biosensor Based on CRISPR/Cas12a and a DNA Tetrahedron for Ultrasensitive Nucleic Acid Detection

Electrochemiluminescent/Electrochemical Ratiometric Biosensor for Extremely Specific and Ultrasensitive Detection of Circulating Tumor DNA

Ultrasensitive detection of circulating tumor DNA using a CRISPR/Cas9 nickase-driven 3D DNA walker based on a COF-AuNPs sensing platform